Hepatitis C Treatment Outcomes for Patients With Infective Endocarditis Treated by an Interdisciplinary Team - Takeaways - MDSpire

Hepatitis C Treatment Outcomes for Patients With Infective Endocarditis Treated by an Interdisciplinary Team

  • By

  • Lauren McQuaide

  • Sami El-Dalati

  • Deborah Gill

  • Bobbi Jo Stoner

  • July 21, 2025

  • 0 min

Share

  • 1

    An interdisciplinary team was established to improve access to hepatitis C treatment for patients with infective endocarditis.

  • 2

    From September 2021 to April 2024, 64 patients with infective endocarditis and HCV were identified, with 75% initiating treatment upon discharge.

  • 3

    Treatment completion was achieved in 69% of patients who started therapy, with loss to follow-up and side effects being the main reasons for discontinuation.

  • 4

    Sustained virologic response at 12 weeks was 42% among those who initiated treatment, and 31% overall, indicating low treatment success.

  • 5

    Further research is needed to explore interventions that could enhance treatment outcomes for patients with endocarditis and HCV.

Original Source(s)

Hepatitis C Treatment Outcomes for Patients With Infective Endocarditis Treated by an Interdisciplinary Team

  • by Lauren McQuaide, Sami El-Dalati, Deborah Gill, Bobbi Jo Stoner

  • July 21, 2025

Related Content

Retrospective Analysis of Direct-Acting Antiviral Treatment Outcomes in Hepatitis C Patients in Saudi Arabia Before and After Therapy

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

Marriage as a Marker of Cancer Risk?

Never-married adults show markedly higher cancer incidence. A large population study asks why marital status remains a footnote in risk frameworks.